Wall Street Journal. Europe 2000 Laura Johannes - Abstracts
| Wall Street Journal. Europe 2000 Laura Johannes | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Bausch & Lomb to begin tender for Wesley Jessen. | Business, international | Laura Johannes | |||
| Gene Therapy Is Showing Promise As a Cancer Fighter. Aventis, Schering-Plough Launch Advanced Trials.(A Bit of Biological Sleight-of-Hand.) | Business, international | Laura Johannes | |||
| Medicines Co. Gets U.S. FDA Approval For Anticlot Drug.(U.S. Food and Drug Administration approves Medicines Co.'s Angiomax) | Business, international | Laura Johannes | |||
| Picture this: Kodak as net king. | Business, international | Laura Johannes, Joann Lublin | |||
| Xerox to slash costs in turnaround effort. | Business, international | Laura Johannes, John Hechinger | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.